Lindbrook Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-182
| Closed | -$5.16K | – | 2893 |
|
|
2023
Q1 | $5.16K | Sell |
182
-95
| -34% | -$2.7K | ﹤0.01% | 1840 |
|
|
2022
Q4 | $8.1K | Buy |
277
+158
| +133% | +$4.62K | ﹤0.01% | 1542 |
|
|
2022
Q3 | $3K | Buy |
+119
| New | +$3K | ﹤0.01% | 1955 |
|
|
2021
Q2 | – | Sell |
-24
| Closed | -$1K | – | 2021 |
|
|
2021
Q1 | $1K | Hold |
24
| – | – | ﹤0.01% | 1822 |
|
|
2020
Q4 | $1K | Hold |
24
| – | – | ﹤0.01% | 1725 |
|
|
2020
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 1686 |
|
|
2020
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 1658 |
|
|
2020
Q1 | $1K | Buy |
+24
| New | +$1K | ﹤0.01% | 1605 |
|